Search - tctmd.com

Displaying 941 - 960 of 1777

Sort: Relevancy | Date

News Daily News

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Todd Neale

May 16, 2016

News Industry News

Cardiome Announces the Launch of ESMOCARD Solution for Injection in France

May 12, 2016

News Daily News

Nestlé Voluntarily Reducing Sodium in Processed Food, but Should the AHA Applaud?

Michael O'Riordan

May 09, 2016

News Opinion Fellow Talk

Your First Job: Deciding What Practice Type Is Right for You

Sarah Elsayed, MD

April 28, 2016

News Daily News

房颤 TAVR 后相关死亡和出血风险增加

Michael O'Riordan

April 18, 2016

News Daily News

La FA Post-TAVR se Asocia a un Mayor Riesgo de Mortalidad y Hemorragias

Michael O'Riordan

April 18, 2016

News Daily News

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Michael O'Riordan

April 18, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Features

Where Theory Meets Practice: Getting to the Heart of the Heart Team

Yael L. Maxwell

March 30, 2016

News Industry News

Advanced Cardiac Therapeutics Successfully Completes Clinical Trial Enrollment

March 28, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Daily News

接受 TAVR 的年满 90 岁患者死亡风险“临床适度”增加

March 23, 2016

News Daily News

Se Observa un ‘Tímido Aumento Clínico’ del Riesgo de Mortalidad en Nonagenarios sometidos a TAVR

March 23, 2016

News Industry News

Silk Road Medical Announces CE Mark Approval and First Patients Treated with the Next Generation ENROUTE® Transcarotid Neuroprotection System

March 16, 2016

News Daily News

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Michael O'Riordan

March 14, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

Advertisement

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Cardiome Announces the Launch of ESMOCARD Solution for Injection in France

Nestlé Voluntarily Reducing Sodium in Processed Food, but Should the AHA Applaud?

Your First Job: Deciding What Practice Type Is Right for You

房颤 TAVR 后相关死亡和出血风险增加

La FA Post-TAVR se Asocia a un Mayor Riesgo de Mortalidad y Hemorragias

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Where Theory Meets Practice: Getting to the Heart of the Heart Team

Advanced Cardiac Therapeutics Successfully Completes Clinical Trial Enrollment

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

接受 TAVR 的年满 90 岁患者死亡风险“临床适度”增加

Se Observa un ‘Tímido Aumento Clínico’ del Riesgo de Mortalidad en Nonagenarios sometidos a TAVR

Silk Road Medical Announces CE Mark Approval and First Patients Treated with the Next Generation ENROUTE® Transcarotid Neuroprotection System

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content